QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies. QuantHealth has one the largest integrated datasets that spans the clinical, pharmacological and biological domains together with a proprietary AI platform that can predict patient-response to both approved and novel therapies.
Company Details
- Employees
- 57
- Founded
- -
- Address
- Tel Aviv, Il
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Drug Simulation, Bioinformatics, RWD/RWE, Computational Biology, Trial Simulation, Patient Centric Drug Development, In-Silico Medicine, Clinical Data Science, Health Informatics, Oncology, Auto-Immune, Respiratory, HemOnc, Drug R&D, Patient Outcomes.
- HQ
- Tel Aviv
Quanthealth Questions
Quanthealth's LinkedIn profile is https://il.linkedin.com/company/quanthealthlabs
Quanthealth has
57 employees.
View email and phone details for 57
employees at Quanthealth.
Quanthealth's industry is
Biotechnology Research
Quanthealth's top competitors are
Immunai,
Quris Ai,
Navina,
Nevia Bio,
Aidoc,
Protai,
Nucleai,
Memed,
Pangea Biomed,
Cytoreason.
Quanthealth's categories are Biotechnology Research
Quanthealth's founding year is 2020
